Breaking News Instant updates and real-time market news.

BRK.A

Berkshire Hathaway

$311,000.00

800 (0.26%)

, BRK.B

Berkshire Hathaway

$205.77

0.605 (0.29%)

16:21
08/14/18
08/14
16:21
08/14/18
16:21

Berkshire Hathaway exits Verisk, boosts stake in Apple and Teva

Warren Buffett's Berkshire Hathaway (BRK.A) disclosed in an SEC filing its holdings as of June 30, 2018. Berkshire had no new buys in the quarter but exited two positions, including Verisk (VRSK). The firm increased its stake in 10 holdings, including by size of previous position Apple (AAPL), U.S. Bancorp (USB), Teva (TEVA), BNY Mellon (BK), and Delta Air Lines (DAL). Berkshire reduced its stake in five holdings, including by size American Airlines (AAL), Phillips 66 (PSX), Charter Communications (CHTR), United Continental (UAL), and Wells Fargo (WFC). Berkshire's top holdings as of June 30 were, in order of size, Apple, Wells Fargo, Kraft Heinz (KHC), Bank of America (BAC), and Coca-Cola (KO).

BRK.A

Berkshire Hathaway

$311,000.00

800 (0.26%)

BRK.B

Berkshire Hathaway

$205.77

0.605 (0.29%)

VRSK

Verisk Analytics

$117.80

1.44 (1.24%)

AAPL

Apple

$209.74

0.865 (0.41%)

USB

U.S. Bancorp

$53.16

0.78 (1.49%)

TEVA

Teva

$22.12

0.17 (0.77%)

BK

BNY Mellon

$50.97

0.825 (1.65%)

DAL

Delta Air Lines

$54.76

0.52 (0.96%)

AAL

American Airlines

$37.08

0.3 (0.82%)

PSX

Phillips 66

$120.95

-0.59 (-0.49%)

CHTR

Charter

$308.03

6.09 (2.02%)

UAL

United Continental

$81.44

0.18 (0.22%)

WFC

Wells Fargo

$58.07

0.43 (0.75%)

KHC

Kraft Heinz

$59.53

0.26 (0.44%)

BAC

Bank of America

$30.80

0.33 (1.08%)

KO

Coca-Cola

$45.89

0.07 (0.15%)

  • 14

    Aug

  • 14

    Aug

  • 20

    Aug

  • 10

    Sep

  • 16

    Sep

  • 24

    Sep

  • 27

    Sep

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

BRK.A Berkshire Hathaway
$311,000.00

800 (0.26%)

07/18/18
MSCO
07/18/18
NO CHANGE
MSCO
Equal Weight
Berkshire amendment signals interest in buying back shares, says Morgan Stanley
After Berkshire Hathaway's board authorized an amendment to the company's share repurchase program, Morgan Stanley analyst Kai Pan noted that Warren Buffett has indicated that the gap between Berkshire's intrinsic value and book value is widening and Pan thinks the amendment signals the company's interest in buying back its own shares. However, Berkshire will not initiate any buybacks until it releases Q2 earnings after market close on Friday, August 3, the analyst notes. Pan, who thinks "solid" Q2 results and buybacks should be positive catalysts, keeps an Equal Weight rating on Berkshire shares.
08/08/18
MSCO
08/08/18
NO CHANGE
Target $67
MSCO
Overweight
Southwest would be good strategic fit for Berkshire, says Morgan Stanley
Morgan Stanley analyst Kai Pan noted that Berkshire Hathaway (BRK.A) has shifted tone in recent years and become a top three shareholder of the "Big Four" U.S. airlines, including Southwest (LUV). Media reports from Forbes, CNN and others have discussed a possible acquisition by Berkshire of the airline, added Pan, who said he has no knowledge of any M&A discussions and noted that the airlines have not commented. Given that background, he analyzed a theoretical acquisition and came to the conclusion that Southwest could be a strategic fit for Berkshire and the advantages could also be compelling for the airline. Pan estimates Berkshire could pay a 20-40% premium, or $70-80 per share for Southwest, in such a hypothetical takeover situation, in which he also thinks Berkshire would divest its current holdings in American Airlines (AAL), Delta (DAL) and United Continental (UAL). Pan has an Overweight rating and $67 price target on Southwest shares.
06/21/18
BERN
06/21/18
NO CHANGE
BERN
Amazon/JPMorgan/Berkshire venture still negative for drug supply chain, says Bernstein
Bernstein analyst Lance Wilkes notes that Amazon (AMZN), Berkshire Hathaway (BRK.A; BRK.B) and JPMorgan (JPM) announced the appointment of Atul Gawande as the CEO of their new healthcare joint venture, effective July 9th. The analyst sees this appointment as indicating an emphasis on enablement of change in the system, along with thought and policy leadership, and believes the appointment of an operating oriented President or COO could refine the outlook for scope. Wilkes continues to see this venture as negative for drug supply chain and self-insured employer oriented MCOs.
08/08/18
08/08/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. REACTIONS TO TESLA'S TALK OF GOING PRIVATE: Jefferies analyst Philippe Houchois raised his price target for Tesla (TSLA) to $360 from $250 after CEO Elon Musk suggested taking the company private. Going private "feels like the right thing to do," Houchois said. "Distraction or not, the move feels right even if Musk is downplaying how supportive public markets have been," the analyst adds. However, with Tesla unable to take on more debt, Houchois wondered who may fund the potential deal and end up as a new large shareholder. While Morgan Stanley analyst Adam Jonas sympathizes with Elon Musk's argument that Tesla could be better off as a private company, he questioned the feasibility of Musk actually being able to achieve that goal. Taking the company private would assume either that the company is on the verge of generating self-sustaining cash flows or that it can tap into a range of strategic sources of capital not previously at its disposal, said Jonas, who sees strategic value at Tesla but thinks the "LBO math required to support [a price of] $420 is extremely aggressive." MORGAN STANLEY SAYS SOUTHWEST A GOOD FIT FOR BERKSHIRE: Morgan Stanley analyst Kai Pan noted that Berkshire Hathaway (BRK.A) has shifted tone in recent years and become a top three shareholder of the "Big Four" U.S. airlines, including Southwest (LUV). Media reports from Forbes, CNN and others have discussed a possible acquisition by Berkshire of the airline, added Pan. He analyzed a theoretical acquisition and came to the conclusion that Southwest could be a strategic fit for Berkshire and the advantages could also be compelling for the airline. Pan estimates Berkshire could pay a 20-40% premium, or $70-80 per share for Southwest, in such a hypothetical takeover situation. Pan has an Overweight rating and $67 price target on Southwest shares. BARCLAYS POSITIVE ON SNAP GUIDANCE CHANGE: Barclays analyst Ross Sandler views Snap's (SNAP) Q2 results as a "mixed bag," with daily active users 2M below his estimate and revenue $20M above his estimate. More importantly, the change in approach towards guidance is "very welcomed and should help to reduce some of the volatility going forward," Sandler said. He believes this is a "big positive for long-term holders looking to get involved." The analyst kept an Overweight rating on Snap with a $16 price target. WAINWRIGHT SAYS INSMED LIKELY TO BE ACQUIRED: H.C. Wainwright analyst Andrew Fein raised his price target for Insmed (INSM) to $43 from $35 following the 12-2 FDA panel vote in favor of ALIS in refractory nontuberculous mycobacterial patients. Insmed is now likely to be acquired as ALIS "fits well within the pipeline of a number of larger companies," Fein said.
BRK.B Berkshire Hathaway
$205.77

0.605 (0.29%)

04/17/18
RHCO
04/17/18
NO CHANGE
Target $44
RHCO
Hold
USG price target raised to $44 from $34 at SunTrust
SunTrust analyst Keith Hughes raised his price target on USG (USG) to $44, saying he expects Knauf to raise its offer price for the company above the latest $42 bid while also anticipating the deal to close. Hughes adds that the support for the deal from Berkshire Hathaway (BRK.B) "greatly increases the odds" that the deal is finalized. Hughes keeps his Hold rating on USG.
05/07/18
LEHM
05/07/18
NO CHANGE
Target $367500
LEHM
Overweight
Berkshire price target raised to $367,500 from $357,000 at Barclays
Barclays analyst Jay Gelb raised his price target for Berkshire Hathaway Class A (BRK.A) to $367,500 from $357,000 and for Class B (BRK.B) to $245 from $238. Berkshire is well positioned to benefit from an expanding economy, higher short-term interest rates, and potential future accretive acquisitions, Gelb tells investors following the company's Q1 results. He keeps an Overweight rating on the shares.
VRSK Verisk Analytics
$117.80

1.44 (1.24%)

02/22/18
WELS
02/22/18
NO CHANGE
Target $115
WELS
Outperform
Verisk Analytics price target raised to $115 from $105 at Wells Fargo
Wells Fargo analyst Bill Warmington raised his price target for Verisk Analytics to $115 from $105 to reflect strong organic cc revenue growth expectations and tax reform. The analyst reiterates an Outperform rating on the shares.
08/02/18
KBWI
08/02/18
DOWNGRADE
Target $118
KBWI
Market Perform
Verisk Analytics downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Arash Soleimani downgraded Verisk Analytics to Market Perform while raising his price target for the shares to $118 from $115. The analyst raised his estimates following the company's Q2 results but downgraded the stock on valuation. He notes the shares are up 20% year-to-date and 32% over the last 12 months.
08/02/18
08/02/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hanesbrands (HBI) downgraded to Equal Weight from Overweight at Barclays with analyst Chethan Mallela saying he sees a lack of visibility into the second half of the year following the company's Q2 results. 2. Royal Dutch Shell (RDS.A) downgraded to Equal Weight from Overweight at Morgan Stanley. 3. Verisk Analytics (VRSK) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Arash Soleimani citing valuation. 4. People's Utah Bancorp (PUB) downgraded to Market Perform at Raymond James with analyst David Long citing valuation. 5. Wendy's (WEN) downgraded to Neutral ahead of Q2 report at Kalinowski with analyst Mark Kalinowski saying his checks indicate July same-store-sales are trending below the +1.5% level and were the worst checks since February 2012. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/22/18
02/22/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Palo Alto Networks (PANW) upgraded to Buy from Neutral at Cleveland Research with the firm saying it's channel partner checks indicate favorable revenue/billings growth in the low-20% range, versus high teens previously, and the product refresh could be a source of upside with increased hardware growth. 2. Verisk Analytics (VRSK) upgraded to Overweight from Neutral at JPMorgan with analyst Andrew Steinerman saying he believes sustainable high-single-digit organic revenue growth is "back in sight" following last night's "strong" fourth quarter results. 3. Tesaro (TSRO) upgraded to Outperform from In Line at Evercore ISI with analyst Steven Breazzano saying he believes the stocks' valuations are now attractive on a long-term basis following their pullbacks. 4. Clovis (CLVS) was upgraded to Outperform from In Line at Evercore ISI and to Outperform from Sector Perform at RBC Capital. 5. Wolverine World Wide (WWW) upgraded to Buy from Neutral at DA Davidson with analyst Andrew Burns saying the company is positioned for accelerating growth following a multi-year restructuring. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AAPL Apple
$209.74

0.865 (0.41%)

08/09/18
JPMS
08/09/18
NO CHANGE
JPMS
Neutral
Lumentum selloff provides attractive entry point, says JPMorgan
JPMorgan analyst Samik Chatterjee believes the post-earnings pullback in shares of Lumentum (LITE) provides an attractive entry point. However, he keeps a Neutral rating on Lumentum with an $80 price target. The shares sold off yesterday as management chose to provide conservative 3D Sensing revenue guidance for fiscal Q2 ahead of greater visibility into market share development and inventory position with its primary customer, Apple (AAPL), on next generation phones expected to be launched in September, Chatterjee tells investors in a research note. Based on his conversations with management, Chatterjee believes the softer guide is driven entirely by a lower market share assumption and budgeting for inventory timing "purely out of conservatism." This increases the likelihood of an upside surprise, the analyst contends.
08/02/18
SBSH
08/02/18
NO CHANGE
Target $5
SBSH
Sell
Citi reiterates Sell on Fitbit, says not an acquisition target
Citi analyst Jim Suva reiterates a Sell rating on Fitbit (FIT) with a $5 price target following the company's Q2 results, which he notes were largely better than expected except for a decline in free cash flow. Apple's (AAPL) smart watch is smarter than Fitbit's (FIT) smartwatches, which do not allow "robust" two-way communication or a lengthy app catalog, and the price differential is immaterial, Suva tells investors in a post-earnings research note. Further, he does not see Fitbit as an acquisition target.
08/01/18
BTIG
08/01/18
NO CHANGE
Target $235
BTIG
Buy
Apple price target raised to $235 from $207 at BTIG
BTIG analyst Walter Piecyk, in a note published last night, raised his price target on Apple (AAPL) shares to $235 from $207, stating that he believes there are early signs that upgrade rates might be bottoming and noting that iPhone revenue grew by over 20% despite "historic low" upgrade rates in Q3. Apple CEO Tim Cook hinted at a noteworthy content project, added Piecyk, who agrees with fellow BTIG analyst Rich Greenfield's view that Apple is likely to follow Netflix (NFLX) and Amazon's (AMZN) approach "build their way into the market rather than buy their way in" to video. Piecyk keeps a Buy rating on Apple shares.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).
USB U.S. Bancorp
$53.16

0.78 (1.49%)

07/09/18
GSCO
07/09/18
NO CHANGE
GSCO
Bank of America, Morgan Stanley top ideas into Q2 earnings season, says Goldman Sachs
Goldman Sachs analyst Richard Ramsden expects Bank of America (BAC) and Morgan Stanley (MS) to beat consensus estimates in Q2. The analyst argues that both appear best positioned, while he sees risk for U.S. Bancorp (USB) and JPMorgan (JPM). Ramsden highlights Bank of America given the material valuation dislocation that looks to support the stock over time. Additionally, the analyst expects an expense and NII beat for Morgan Stanley.
05/11/18
SBSH
05/11/18
UPGRADE
Target $58
SBSH
Buy
Citi upgrades U.S. Bancorp, says opportune time to build positions
Citi analyst Keith Horowitz upgraded U.S. Bancorp to Buy from Neutral with an unchanged price target of $58. Now is an opportune time to build positions in the stock after three years of significant underperformance, Horowitz tells investors in a research note. He believes the drivers of the underperformance have largely played out and that U.S. Bancorp's efficiency ratio will improve from here. Further, the bank's "strong" credit quality profile can be a differentiator as the cycle gets into the latter innings, Horowitz contends. He says U.S. Bancorp is one of the best ways for investors looking to add exposure to the banks.
05/11/18
05/11/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Verizon (VZ) upgraded to Overweight from Neutral at JPMorgan with analyst Philip Cusick saying after a meeting with CEO Lowell McAdam, he has a better understanding that Verizon's "organic approach to wireless has the company on an increasingly stable footing." 2. Mosaic (MOS) upgraded to Outperform from Sector Perform at RBC Capital with analyst Andrew Wong saying that it is "hard to ignore the improving undercurrents in both phosphate and potash markets." 3. Ultragenyx (RARE) upgraded to Overweight from Equal Weight at Barclays with analyst Gena Wang saying she thinks a higher price target for Crysvita could drive upside to revenue growth expectations. 4. U.S. Bancorp (USB) upgraded to Buy from Neutral at Citi with analyst Keith Horowitz saying now is an opportune time to build positions in the stock after three years of significant underperformance. 5. AMC Networks (AMCX) upgraded to Buy from Hold at Gabelli with the firm saying it remains an excelling company with opportunities to leverage its recent programming momentum into increased advertising and affiliate fees. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/18/18
SPHN
07/18/18
NO CHANGE
Target $105
SPHN
Overweight
Comerica could be viewed as acquisition target, says Stephens
Stephens analyst Terry McEvoy raised his capital payout forecast for Comerica (CMA) for the second half of this year and for 2019 as he expects the company will announce an increase in the dividend and larger buyback plan after its board meets on July 24. Additionally, McEvoy thinks Comerica could be viewed as an takeover target once BB&T (BBT) and U.S. Bancorp (USB) are in a position to acquire banks. Stating that he likes both its fundamental and strategic outlook, McEvoy keeps an Overweight rating and $105 price target on Comerica shares.
TEVA Teva
$22.12

0.17 (0.77%)

08/08/18
FBCO
08/08/18
NO CHANGE
FBCO
Credit Suisse remains cautiously optimistic on Teva's Fremanezumab approval
Credit Suisse analyst Vamil Divan believes Celltrion press releases and Teva's comments still point to September approval for Fremabezumab. While the analyst would certainly prefer a cleaner story heading into the Action Date, he is comfortable enough with the company comments to maintain a cautiously optimistic view.
08/07/18
STFL
08/07/18
INITIATION
Target $30
STFL
Buy
Alder Biopharmaceuticals initiated with a Buy at Stifel
Stifel analyst Paul Matteis initiated coverage of Alder BioPharmaceuticals with a Buy rating and $30 price target, calling it an attractive, differentiated "pure play" within the migraine antiCGRP prevention market. While Matteis acknowledges it "won't be easy" for Alder to compete with Amgen (AMGN), Novartis (NVS), Eli Lilly (LLY) and Teva (TEVA), he believes the unique profile of eptinezumab remains underappreciated and may allow it to capture meaningful, above consensus share of a large, emerging drug category.
08/02/18
WELS
08/02/18
NO CHANGE
WELS
Market Perform
Mylan may have negative read-through from Teva report, says Wells Fargo
Wells Fargo analyst David Maris highlighted some items in Teva's (TEVA) Q2 earnings report and conference call that he believes may have a negative read-through for Mylan (MYL). For one, Teva management said they expect the North American generics environment to remain challenging. Additionally, Copaxone sales were relatively flat sequentially, which would be a negative for Mylan if expectations are for increased contribution from Mylan's Copaxone generic in Q2. Mylan has a large pipeline of biosimilars and Teva mentioned it is building a facility for biosimilars in Germany, which indicates more competition, added Maris, who keeps a Market Perform rating on Mylan shares.
08/07/18
MZHO
08/07/18
NO CHANGE
Target $27
MZHO
Buy
Teva still confident in migraine drug approval, says Mizuho
Teva traded lower yesterday on news that Celltrion received a Form 483 related to an FDA inspection of its plant, Mizuho analyst Irina Koffler tells investors in a research note. The analyst says Teva management indicated to her that it had knowledge of 483 report at the time of its earnings call and still has confidence in approval of its migraine drug. Koffler keeps a Buy rating on Teva Pharmaceutical with a $27 price target.
BK BNY Mellon
$50.97

0.825 (1.65%)

03/07/18
03/07/18
UPGRADE
Target $58

Neutral
BNY Mellon upgraded to Neutral on balanced risk/reward at BofA/Merrill
As previously reported, BofA/Merrill upgraded BNY Mellon to Neutral from Underperform and raised tis price target to $58 from $54. Analyst Michael Carrier expects this week's investor Day to be a positive event, highlighting growth initiatives, cost efficiencies and capital management. Carrier views risk/reward as more balanced saying business trends are decent, but some headwinds remain.
03/12/18
GSCO
03/12/18
DOWNGRADE
Target $60
GSCO
Neutral
BNY Mellon downgraded to Neutral on valuation at Goldman Sachs
Goldman analyst Alexander Blostein downgraded BNY Mellon to Neutral from Buy citing valuation reflects near-term earnings growth and maintained a $60 price target.
03/07/18
BOFA
03/07/18
UPGRADE
BOFA
Neutral
BNY Mellon upgraded to Neutral from Underperform at BofA/Merrill
07/12/18
RAJA
07/12/18
DOWNGRADE
RAJA
Market Perform
BNY Mellon downgraded to Market Perform from Outperform at Raymond James
DAL Delta Air Lines
$54.76

0.52 (0.96%)

07/16/18
LEHM
07/16/18
NO CHANGE
Target $68
LEHM
Equal Weight
Barclays lowers Airlines targets to reflect 'more realistic' valuations
Barclays analyst Brandon Oglenski reduced his price targets across the North America Airlines group to reflect near-term earnings headwinds from higher fuel prices as well as a "more realistic valuation outlook." Nonetheless, domestic U.S. demand "appears quite strong," with 2018 industry revenue expected to expand high single digits, Oglenski tells investors in a research note. He believes discussion of incremental capacity reductions through earrings season could help put a floor in stock prices. The analyst lowered his price target for Underweight-rated Allegiant Travel Company (ALGT) to $117 from $135, for Equal Weight-rated Alaska Air Group (ALK) to $68 from $80, for Overweight-rated American Airlines Group (AAL) to $60 from $68, for Overweight-rated Delta Air Lines (DAL) to $62 from $73, for Overweight-rated JetBlue Airways (JBLU) to $27 from $29, for Equal Weight-rated Southwest Airlines (LUV) to $65 from $74, for Equal Weight-rated Spirit Airlines (SAVE) to $42 from $49 and for Overweight-rated United Continental Holdings (UAL) to $78 from $80.
07/03/18
07/03/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. United Continental (UAL), American Airlines (AAL), and Delta Airlines (DAL) downgraded to Hold from Buy at Deutsche Bank with analyst Michael Linenberg saying in a world of "heightened" macroeconomic and geopolitical risks, economically-sensitive, high beta stocks such as airlines typically underperform the broader market. 2. Belmond (BEL) downgraded to Underweight from Overweight at Barclays with analyst Felicia Hendrix citing an analysis of the company's progress on its growth targets announced back in June 2016. 3. PSEG (PEG) downgraded to Hold from Buy at Deutsche Bank with analyst Jonathan Arnold saying The Federal Energy Regulatory Commission order raised new questions over New Jersey zero-emission credits. 4. PepsiCo (PEP) downgraded to Hold from Buy at Deutsche Bank with analyst Stephen Powers viewing the current valuation as a "bit bubbly." 5. Watsco (WSO), Fastenal (FAST), and Grainger (GWW) downgraded to Neutral from Outperform at Baird with analyst David Manthey saying he thinks the cycle and individual company results could remain solid for quarters or years to come, but he believes the cycle is in its later stages, thereby elevating risks to gross margins, rising labor costs, and earnings deceleration in 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/03/18
DBAB
07/03/18
NO CHANGE
DBAB
Deutsche downgrades three airlines on 'headline risk' from trade dispute
Deutsche Bank analyst Michael Linenberg downgraded his ratings on American Airlines Group (AAL), Delta Air Lines (DAL) and United Continental (UAL) to Hold from Buy. The analyst cut his price target for American to $43 from $60, for Delta to $53 from $64 and for United to $74 from $81. In a world of "heightened" macroeconomic and geopolitical risks, economically-sensitive, high beta stocks such as airlines typically underperform the broader market, Linenberg tells investors in a research note. The possibility that the current trade dispute between the U.S. and its global partners could become something bigger is problematic for the airline industry's sales growth, the analyst adds. Further, Linenberg argues, the growing trade dispute may cause U.S. companies to reconsider their spending and employment plans, which would adversely impact corporate travel. As a result, the analyst sees "headline risk" and a lack of near-term catalysts for the airline stocks. He keeps Buy ratings on Alaska Air (ALK), Allegiant Travel (ALGT), JetBlue Airways (JBLU), Southwest Airlines (LUV), Spirit Airlines (SAVE) and SkyWest (SKYW).
AAL American Airlines
$37.08

0.3 (0.82%)

07/30/18
MACQ
07/30/18
UPGRADE
MACQ
Outperform
American Airlines upgraded to Outperform from Neutral at Macquarie
07/30/18
07/30/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AT&T (T) upgraded to Buy from Neutral at BofA/Merrill with analyst David Barden saying he is positive on AT&T's 20-year low P/E multiple, Timer Warner (TWX) merger benefits of earnings accretion and expanding cash, favorable emerging wireless business trends, and a call option on value extraction from the merger of AT&T's distribution network with Time Warner's content and ad inventory. 2. American Airlines (AAL) upgraded to Outperform from Neutral at Macquarie. 3. Avis Budget (CAR) upgraded to Buy from Neutral at Northcoast. 4. Cabot Oil & Gas (COG) upgraded to Positive from Neutral at Susquehanna with analyst Biju Perincheril citing the recent weakness in the shares but he also feels the risk/reward is attractive with many projects providing production growth over the next two years along with accelerating free cash flow generation. 5. Juniper (JNPR) upgraded to Buy from Hold at Deutsche Bank with analyst Vijay Bhagavath saying he's "going against the grain" and making a "contrarian call." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PSX Phillips 66
$120.95

-0.59 (-0.49%)

07/05/18
GSCO
07/05/18
NO CHANGE
Target $136
GSCO
Buy
Phillips 66 preferred among diversified refiners, says Goldman Sachs
Goldman Sachs analyst Neil Mehta writes that gasoline margins by U.S. refiners have come in below expectations so far this summer amid "elevated refining utilization, high gasoline yield, slowing demand trends, and the lag between higher Brent prices and product realization". In his broader sector research note, the analyst states that Phillips 66 (PSX) is his preferred name among the stocks featuring favorable crude differentials/diversified business mixes rather than merchant refining assets with coastal exposure, keeping his Buy rating and $136 price target on the shares because of the company's premium free cash flow generation. Mehta is also positive on CVR Refining (CVRR) and Delek Holdings (DK) based on their "advantaged crude slates", but remains at a Sell for PBF Energy (PBF) because its East Coast/California/Gulf Coast assets are "less exposed to favorable crude discounts and are more closely tied to product margins".
08/01/18
MZHO
08/01/18
INITIATION
Target $124
MZHO
Neutral
Phillips 66 initiated with a Neutral at Mizuho
Mizuho initiated Phillips 66 with a Neutral and $124 rice target.
06/29/18
USCA
06/29/18
UPGRADE
USCA
Overeight
Phillips 66 upgraded to Overeight from Hold at US Capital Advisors
06/04/18
FBCO
06/04/18
NO CHANGE
Target $122
FBCO
Neutral
Phillips 66 price target raised to $122 from $115 at Credit Suisse
Credit Suisse analyst Manav Gupta raised his price target for Phillips 66 to $122 from $115 as he expects wider heavy light diffs and light-light diffs to work in PSX favor. The analyst reiterates a Neutral rating on the shares.
CHTR Charter
$308.03

6.09 (2.02%)

08/02/18
RILY
08/02/18
NO CHANGE
Target $62
RILY
Buy
GCI Liberty price target lowered to $62 from $70 at B. Riley FBR
B. Riley FBR analyst Barton Crockett lowered his price target for GCI Liberty (GLIBA) to $62 after updating his sum-of-the-parts analysis. The analyst still sees potential upside of 30%-plus, likely realized over next couple years via a merger with Charter Communications (CHTR). Charter is likely interested in GCI Liberty because of its holdings of Charter-related equity and its Alaskan cable business, Crockett tells investors in a research note. He keeps a Buy rating on GCI.
07/30/18
BUCK
07/30/18
NO CHANGE
Target $397
BUCK
Buy
Forced sale of Charter's New York assets seems unlikely, says Buckingham
Buckingham analyst Matthew Harrigan noted that New York's Public Service Commission has moved to push Charter out of the state and presented the company with a 60 day ultimatum to find a buyer for its assets there due to what it views as "repeated failures" to honor its commitments around the 2016 merger with Time Warner Cable. While he thinks an extended court battle seems "virtually certain," Harrigan does not see much likelihood of any forced disposition of its New York State assets. He keeps a Buy rating and $397 price target on Charter shares.
07/24/18
MKMP
07/24/18
NO CHANGE
Target $10
MKMP
Neutral
Infinera price target lowered to $10 from $12.50 at MKM Partners
MKM Partners analyst Michael Genovese lowered his price target on Infinera (INFN) to $10 and kept his Neutral rating after its $430M purchase of Coriant, saying the company believes that integration of key Optical and DSP technology will give it a competitive advantages. He also believes the deal "is a significant headwind for Acacia (ACIA) "since Infinera will look to move Coriant to its own vertically integrated technology platform". The analyst further notes that while Infinera preannounced Q2, the absence of Q3 guidance accompanying the deal suggests that the outlook may be at risk from reduced Charter Communications (CHTR) sales. Genovese concludes that Infinera may struggle to make up the 14% related revenue headwind to generate "flat to slightly up" Q3 sales.
07/30/18
07/30/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA UPGRADES AT&T TO BUY: Bank of America Merrill Lynch upgraded AT&T (T) to Buy from Neutral as analyst David Barden is positive on AT&T's 20-year low P/E multiple, Timer Warner merger benefits, favorable emerging wireless business trends, and a call option on value extraction from the merger of AT&T's distribution network with Time Warner's content and ad inventory. He keeps a $37 price target on AT&T shares. DEUTSCHE UPS JUNIPER IN 'CONTRARIAN' CALL: Deutsche Bank analyst Vijay Bhagavath upgraded Juniper Networks (JNPR) to Buy from Hold and raised his price target for the shares to $32 from $25. The analyst said he's "going against the grain" and making a "contrarian call." The post-earnings selloff on the "better than feared" Q2 results and below consensus Q3 guidance, which is primarily related to switch router upgrade timing at a handful of cloud and service provider customers, provides a "reasonable entry point." He believes "robust" switch router and next generation security refresh cycles will start in fiscal 2019 and that Juniper's fundamentals will improve from FY19 through FY21. STIFEL CUTS SYNCHRONOS TO SELL: Stifel analyst Tom Roderick downgraded Synchronoss (SNCR) to Sell from Hold, stating that recent filings reveal that liquidity issues loom, the company is "out of levers, and time is not on their side." The turnaround required to keep the company from fundraising "feels Herculean," added Roderick, who lowered his price target on Synchronoss shares to $3 from $8. BUCKINGHAM SAYS FORCED SALE OF CHARTER ASSETS 'UNLIKELY': Buckingham analyst Matthew Harrigan noted that New York's Public Service Commission has moved to push Charter (CHTR) out of the state and presented the company with a 60 day ultimatum to find a buyer for its assets there due to what it views as "repeated failures" to honor its commitments around the 2016 merger with Time Warner Cable. While he thinks an extended court battle seems "virtually certain," Harrigan does not see much likelihood of any forced disposition of its New York State assets. He keeps a Buy rating and $397 price target on Charter shares.
UAL United Continental
$81.44

0.18 (0.22%)

07/19/18
BUCK
07/19/18
NO CHANGE
Target $106
BUCK
Buy
United Continental price target raised to $106 from $96 at Buckingham
Buckingham analyst Daniel McKenzie raised his price target on United Continental to $106 and kept his Buy rating after its better than expected Q2 unit revenue and Q3 outlook. The analyst says the management "succinctly articulated a "no-excuses" EPS goal of $11-$13 in 2020", adding that even in the event of an economic downturn, the airline has "plenty of capacity flexibility". McKenzie further notes that United Continental's raised earnings guidance "adds credibility" to the business plan, stating he is confident that the airline can continue executing on top-line growth, with industry supply up just 2.9% and demand on the rise.
07/19/18
07/19/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Square (SQ) upgraded to Outperform from Neutral at Credit Suisse WITH analyst Paul Condra saying he believes its growing product eco-system is increasing its ability to penetrate larger merchants, positive data points on Cash-App adoption validate Square's two-sided platform strategy to grow both merchant and consumer use-cases, and growth investing should support strong revenue trends driving upside to revenue forecasts in the out-years. 2. Discovery (DISCA) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Drew Borst saying Discovery's acquisition of Scripps creates "meaningful" cost and revenue synergy opportunities. 3. Grainger (GWW) upgraded to Neutral from Sell at UBS with analyst Steven Winoker saying the company's strategic initiatives, including its pricing reset and e-commerce platform development, reposition it to gain market share through 2019. 4. Hilton (HLT) upgraded to Buy from Hold at Berenberg. 5. United Continental (UAL) upgraded to Outperform from Neutral at Macquarie. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/18
MACQ
07/19/18
UPGRADE
Target $95
MACQ
Outperform
United Continental upgraded to Outperform on continued execution at Macquarie
As previously reported, Macquarie upgraded United Continental to Outperform from Neutral with a $95 price target. Analyst Susan Donofrio said United is demonstrating its ability to execute on commercial initiatives following another beat and raise quarter and demonstrates its earnings growth ability in a rising fuel environment.
WFC Wells Fargo
$58.07

0.43 (0.75%)

07/20/18
OPCO
07/20/18
NO CHANGE
OPCO
Perform
Wells Fargo's next few earnings reports likely to be 'choppy,' says Oppenheimer
Oppenheimer analyst Chris Kotowski maintained a Perform rating on Wells Fargo (WFC) after recent meetings with CFO John Shrewsberry. In a research note to investors, Kotowski says there was nothing that shakes his view that the next few quarterly earnings reports are likely to still be "choppy," and notes that Shewsberry "readily acknowledged" that there was much work to be done to get the consent order lifted. At the same time, the analyst contends that shares are not trading at much of a discount versus other high performing banks like JPMorgan (JPM) and PNC (PNC) and says he favors companies that have lower but rising ROTCEs that are trading near TBV, especially Citi (C), CIT (CIT) and Goldman (GS).
07/16/18
07/16/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Kleinhanzl saying current share levels offer an attractive entry point for a "self-help stock" that can generate "material" earnings growth near-term. 2. VF Corp. (VFC) upgraded to Overweight from Neutral at JPMorgan with analyst Matthew Boss saying he sees an attractive risk/reward profile at current share levels given the company's "multi-year inflection." 3. UPS (UPS) upgraded to Buy from Neutral at UBS with analyst Thomas Wadewitz saying the combination of cost and productivity improvements, coupled with a constructive" revenue backdrop, provide potential for improved Domestic Package margin performance and stronger operating income growth in 2019 for UPS. 4. Autoliv (ALV) upgraded to Outperform from Neutral at Daiwa. 5. Saratoga Investment (SAR) upgraded to Buy from Neutral at Compass Point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/16/18
BMOC
07/16/18
NO CHANGE
Target $61
BMOC
Market Perform
Wells Fargo price target raised to $61 at BMO Capital after in-line Q2
BMO Capital analyst James Fotheringham kept his Market Perform rating and nudged his price target on Wells Fargo (WFC) to $61 from $59 after the company's in-line Q2 "core" results which also showed higher than expected net interest margins and lower loss provisions. The analyst notes that after relative underperformance by the financials sector this year, he would recommend that investors buy "inexpensive stocks with near-term catalysts", including Santander (SC), OneMain (OMF), and Synchony (SYF).
07/15/18
KBWI
07/15/18
UPGRADE
Target $63
KBWI
Outperform
Wells Fargo upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl upgraded Wells Fargo to Outperform and raised his price target for the shares to $63 from $57. The stock closed Friday down 67c to $55.36. Current share levels offer an attractive entry point for a "self-help stock" that can generate "material" earnings growth near-term, Kleinhanzl tells investors in a research note. The analyst saw enough in Wells Fargo's most recent quarter to get him more constructive. He raised his earnings estimates and sees additional upside if management can drive expenses toward the company's investor day simulation range of $50B-$51B in 2020. Kleinhanzl sees expense saves and capital returns driving shares of Wells Fargo higher.
KHC Kraft Heinz
$59.53

0.26 (0.44%)

08/14/18
PIPR
08/14/18
NO CHANGE
Target $35
PIPR
Underweight
Piper views sale of Campbell Soup as unlikely
Piper Jaffray analyst Michael Lavery does not expect a sale of Campbell Soup (CPB) to be part of its strategic update. Rather, the analyst thinks the company will focus on how it can turn around its business. He believes spending increases are needed and that a C-Fresh divestiture is likely, but with only modest proceeds. He thinks Kraft Heinz (KHC), viewed as a potential bidder if Campbell Soup were for sale, "prefers brands with stronger equity and market share positions and may not be interested." Lavery lowered his price target for Campbell shares to $35 from $36 and keeps an Underweight rating on the name.
06/26/18
BERN
06/26/18
NO CHANGE
BERN
Kraft Heinz buying Campbell will not solve 'perception problem,' says Bernstein
Bernstein analyst Alexia Howard note that The New York Post reported that Kraft Heinz (KHC) would be interested in buying Campbell Soup (CPB) should the company decide to put itself up for sale. Based on her accretion analysis, the analyst believes the deal could be slightly EPS dilutive before synergies, and 13%-22% accretive for Kraft Heinz after incorporating cost synergies. Despite the potential EPS accretion, Kraft Heinz buying Campbell Soup will not solve the company's "perception problem," Howard contends, adding that there seems to be a belief that the boards of potential target companies may be unwilling to sell to Kraft Heinz because of the company's poor track record of managing the top line, particularly in the U.S.
06/26/18
SBSH
06/26/18
NO CHANGE
SBSH
Buy
Citi sees 'low probability' of Campbell Soup putting itself up for sale
After the New York Post said that Kraft Heinz (KHC) would be interested in acquiring Campbell Soup (CPB), Citi analyst David Driscoll said he thinks Campbell deciding to sell itself entirely is a "low probability event" and he believes the company is more likely to pursue divestitures. However, in the low probability scenario that Campbell is put up for sale, his "unconventional pick" for a buyer is Conagra (CAG) rather than Kraft, Driscoll added. He maintains a Buy rating on Campbell Soup shares, which closed up 9% at $42.23 yesterday following the Post's report.
06/26/18
PIPR
06/26/18
NO CHANGE
Target $36
PIPR
Underweight
Sell Campbell Soup shares on recent strength, says Piper Jaffray
After The New York Post reported that Kraft Heinz (KHC) would potentially be interested in buying Campbell Soup (CPB), Piper Jaffray analyst Michael Lavery said he would not consider this deal consistent with Kraft's desire for strong brands that can travel internationally. In a research note to investors, Lavery said his bullish view of Kraft Heinz rests in part on his expectation that a deal helps improve its long-term growth outlook, and added that while a Campbell deal could be a bridge to others, he believes it could seem "disappointing" relative to other potential targets." Lavery added that "anything is possible," but would sell Campbell shares on recent strength. Lavery has an Underweight rating and $36 price target on Campbell Soup and an Overweight rating and $73 price target on Kraft Heinz.
BAC Bank of America
$30.80

0.33 (1.08%)

07/17/18
BARD
07/17/18
NO CHANGE
Target $30
BARD
Neutral
Baird would be buyers of Bank of America on weakness
Baird analyst David George said he would remain a buyer of Bank of America shares on any weakness, stating that its operating leverage was impressive in Q2 and should continue along with solid execution. George maintained his Neutral rating and $30 price target on Bank of America shares.
04/17/18
BMOC
04/17/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America is the best of the 'big four' U.S. banks, says BMO Capital
BMO Capital analyst James Fotheringham kept his Market Perform rating and $34 price target on Bank of America (BAC) after its in-line Q1 earnings but raised his FY18 EPS view to $2.62 from $2.59 and FY19 view to $3.18 from $3.12. Fotheringham says than in contrast, he lowered earnings forecasts for JPMorgan (JPM), Wells Fargo (WFC), and Citigroup (C) because of higher costs and lower revenues, but Bank of America's better than expected net interest income rise justifies his view of the bank as the "best of the bunch". The analyst also notes the bank's more favorable valuation trading at a below-average two-year-forward P/E multiple despite his forecast of double the core earnings growth rate of Bank of America's peers.
04/03/18
BMOC
04/03/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America pullback provides a buying opportunity, says BMO Capital
BMO Capital analyst James Fotheringham says that the recent near-10% pullback in the Bank of America stock price provides investors with a buying opportunity. The analyst contends that the bank's stock trades much more closely in line with short term interest rates rather than the 10-year and believes that its net interest margins will prove to be "insensitive" to lower yields on the benchmark as well as higher LIBOR-OIS spreads. Fotheringham keeps his $34 price target and Market Perform rating on Bank of America, adding that its current two-year-forward P/E valuation multiple is close to its long-term historical average.
KO Coca-Cola
$45.89

0.07 (0.15%)

07/26/18
RHCO
07/26/18
NO CHANGE
Target $55
RHCO
Buy
Coca-Cola price target raised to $55 from $50 at SunTrust
SunTrust analyst William Chappell raised his price target on Coca-Cola to $55 and kept his Buy rating, saying the company addressed his concerns about the negative price-mix in North America as pricing actually rose in low-single-digits in Q2. The analyst notes that his new price target implies a forward price earnings multiple of 24-times - a premium relative to peers based on the company's "strong organic growth performance".
08/14/18
EVER
08/14/18
NO CHANGE
EVER
BodyArmor stake positive for Coca-Cola, negative for Pepsi, says Evercore
Evercore ISI analyst Robert Ottenstein views Coca-Cola's stake in BodyArmor as a "clear positive" for the company and a "clear negative" for both PepsiCo (PEP) and Keurig Dr Pepper (KDP). Pepsi's Gatorade product is most at risk with Coca-Cola taking a stake in BodyArmor, and Keurig Dr Pepper "losses distribution of the product and any path to ownership it might have enjoyed," Ottenstein tells investors in a research note.
07/16/18
RBCM
07/16/18
NO CHANGE
Target $75
RBCM
Outperform
Monster Beverage price hike to come November 1st, says RBC Capital
RBC Capital analyst Nik Modi says his industry sources have confirmed that Monster Beverage (MNST) intends to raise its prices by 4.0-5.5% on November 1st depending on the pack size, which would be in line with the management's indication of pricing review made at the June shareholder meeting. The analyst keeps his Outperform rating and $75 price target on Monster, adding that Coca Cola (KO), PepsiCo (PEP) and Keurig Dr Pepper (KDP) will also likely make pricing changes in response over the coming months.

TODAY'S FREE FLY STORIES

NEM

Newmont Mining

$31.56

0.05 (0.16%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Syndicate
Breaking Syndicate news story on Newmont Mining »

Newmont Mining files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Oct

CB

Chubb

$139.87

-0.05 (-0.04%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Hot Stocks
Chubb CEO Greenberg sells $8.6M in common stock »

Chubb CEO Evan Greenberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTVT

vTv Therapeutics

$0.80

0.0096 (1.21%)

17:21
09/21/18
09/21
17:21
09/21/18
17:21
Hot Stocks
vTv says FDA advised that azeliragon efficacy be shown in at least 2 trials »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VYGR

Voyager Therapeutics

$18.21

-0.27 (-1.46%)

17:17
09/21/18
09/21
17:17
09/21/18
17:17
Hot Stocks
Breaking Hot Stocks news story on Voyager Therapeutics »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNRC

Generac

$57.99

-0.02 (-0.03%)

17:16
09/21/18
09/21
17:16
09/21/18
17:16
Hot Stocks
Generac announces new $250M share repurchase program »

The company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBNK

Guaranty Bancorp

$30.20

-0.5 (-1.63%)

, IBTX

Independent Bank

$67.60

-1.15 (-1.67%)

17:13
09/21/18
09/21
17:13
09/21/18
17:13
Conference/Events
Independent Bank to host special shareholder meeting »

Special Shareholder…

GBNK

Guaranty Bancorp

$30.20

-0.5 (-1.63%)

IBTX

Independent Bank

$67.60

-1.15 (-1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

HRS

Harris

$164.33

1.685 (1.04%)

17:13
09/21/18
09/21
17:13
09/21/18
17:13
Hot Stocks
Harris awarded $255.4M Department of Defense contract »

Harris Corp has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PMBC

Pacific Mercantile Bancorp

$9.25

-0.5 (-5.13%)

17:10
09/21/18
09/21
17:10
09/21/18
17:10
Hot Stocks
Breaking Hot Stocks news story on Pacific Mercantile Bancorp »

FJ Capital Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

WSC

WillScot

$17.10

-0.05 (-0.29%)

17:10
09/21/18
09/21
17:10
09/21/18
17:10
Syndicate
Breaking Syndicate news story on WillScot »

WillScot files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTEA

DAVIDsTEA

$2.50

-0.9 (-26.47%)

17:09
09/21/18
09/21
17:09
09/21/18
17:09
Hot Stocks
Breaking Hot Stocks news story on DAVIDsTEA »

TDM Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$23.45

0.3 (1.30%)

, EXPE

Expedia

$133.73

-0.77 (-0.57%)

17:08
09/21/18
09/21
17:08
09/21/18
17:08
Hot Stocks
Expedia president Bhutani joins New York Times board »

The New York Times…

NYT

New York Times

$23.45

0.3 (1.30%)

EXPE

Expedia

$133.73

-0.77 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBTX

Independent Bank

$67.60

-1.15 (-1.67%)

, GBNK

Guaranty Bancorp

$30.20

-0.5 (-1.63%)

17:08
09/21/18
09/21
17:08
09/21/18
17:08
Conference/Events
Guaranty Bancorp to host special shareholder meeting »

Special Shareholder…

IBTX

Independent Bank

$67.60

-1.15 (-1.67%)

GBNK

Guaranty Bancorp

$30.20

-0.5 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

, ANDV

Andeavor

$154.80

2.19 (1.44%)

17:01
09/21/18
09/21
17:01
09/21/18
17:01
Conference/Events
Andeavor to host special shareholder meeting »

Special Shareholder…

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

ANDV

Andeavor

$154.80

2.19 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

ANDV

Andeavor

$154.80

2.19 (1.44%)

, MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

16:59
09/21/18
09/21
16:59
09/21/18
16:59
Conference/Events
Marathon Petroleum to host special shareholder meeting »

Special Shareholder…

ANDV

Andeavor

$154.80

2.19 (1.44%)

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

EPRT

Essential Properties Realty Trust

$14.49

-0.015 (-0.10%)

16:45
09/21/18
09/21
16:45
09/21/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Essential Properties Realty Trust »

Integrated Core…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBSI

Barrett Business

$63.67

0.04 (0.06%)

16:43
09/21/18
09/21
16:43
09/21/18
16:43
Hot Stocks
SEC says Barrett Business to pay $1.5M penalty over improper accounting »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIGA

Siga Technologies

$7.25

0.5 (7.41%)

16:42
09/21/18
09/21
16:42
09/21/18
16:42
Conference/Events
Siga Technologies to host business news update conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

SPY

SPDR S&P 500 ETF Trust

$292.03

-0.1774 (-0.06%)

, USO

United States Oil Fund

$14.95

0.145 (0.98%)

16:36
09/21/18
09/21
16:36
09/21/18
16:36
General news
Weekly CFTC Commitment of Traders highlights »

S&P500 net long 0.1K…

SPY

SPDR S&P 500 ETF Trust

$292.03

-0.1774 (-0.06%)

USO

United States Oil Fund

$14.95

0.145 (0.98%)

GLD

SPDR Gold Trust

$113.48

-0.77 (-0.67%)

FXE

Euro Currency Trust

$112.55

-0.27 (-0.24%)

FXC

CurrencyShares Canadian Dollar Trust

$76.37

-0.09 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMCF

Emclaire Financial

$37.90

0.84 (2.27%)

16:36
09/21/18
09/21
16:36
09/21/18
16:36
Hot Stocks
Emclaire Financial announces shareholder, regulatory approval of merger »

Emclaire Financial and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

16:32
09/21/18
09/21
16:32
09/21/18
16:32
Conference/Events
Roche to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

IDA

IDACORP

$99.23

0.555 (0.56%)

16:31
09/21/18
09/21
16:31
09/21/18
16:31
Hot Stocks
IDACORP raises quarterly dividend 6.8% to 63c per share »

IDACORP announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
09/21/18
09/21
16:30
09/21/18
16:30
Options
Preliminary option volume of 23.2M today »

Preliminary option volume…

ARGO

Argo Group

$61.50

1.3 (2.16%)

16:24
09/21/18
09/21
16:24
09/21/18
16:24
Syndicate
Breaking Syndicate news story on Argo Group »

Argo Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
09/21/18
09/21
16:20
09/21/18
16:20
Options
Closing CBOE SPX and VIX Index summary for September 21st »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
09/21/18
09/21
16:17
09/21/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.